-69%

est. 2Y upside i

FinTechSeries A

Symbiotic is the universal staking protocol enabling protocols to streamline decentralizing their stack. Symbiotic enables creating fully custom or templated staking integrations leveraging any asset and features such as slashing, redistribution, (liquid) restaking, as well as native staking. Over 40 teams including Spark, Hyperlane, and Avail are building on Symbiotic’s universal staking primitives secured by over $1bn in TVL.

Rank

#1378

Sector

Fintech, Cryptocurrency/Blockchain

Est. Liquidity

~4Y

Data Quality

Data: Medium

Symbiotic presents a moderate upside opportunity for a job seeker.

Last updated: March 10, 2026

Bull (20%)+300%

Symbiotic's 'universal staking' framework achieves significant market penetration by securing over 70+ diverse protocols, including Bitcoin-native services, and successfully launching 'Curator Markets' by mid-2026. This differentiation and rapid adoption drive its valuation to $1.2B, establishing it as a critical piece of Web3 infrastructure despite incumbent competition.

Base (40%)+100%

Symbiotic continues its strong growth trajectory, expanding its network integrations and maintaining over $1B in TVL, but faces persistent competition from EigenLayer. It secures a solid niche in the universal staking market, leading to a valuation of $600M, representing a healthy return for early equity holders.

Bear (40%)-75%

EigenLayer's dominant market position and network effects prove too strong, limiting Symbiotic's growth and market share. Regulatory uncertainties in the staking sector or slower-than-expected adoption of its universal staking model lead to a down round or a significantly reduced valuation of $75M, severely impacting common stock value.

Est. time to liquidity~3.5 years

Preference Stack Risk

moderate

Investors hold $34.8M in liquidation preferences ahead of common stock. In an exit at or below the estimated $300M valuation, common shareholders would receive a reduced payout.

Dilution Risk

high

As a Series A company, Symbiotic is likely to undergo additional funding rounds, which will lead to further dilution of existing equity holders.

Secondary Liquidity

none

There is currently no indication of active secondary markets or tender offers for Symbiotic's private equity.

Engineering — 1 role

Marketing — 1 role

Other — 1 role

View all 3 open roles at Symbiotic →

Last updated: March 8, 2026

Questions to Ask at the Interview

Strategic questions based on Symbiotic's data — designed to show you've done your homework.

  • 1

    “Given EigenLayer's established dominance and TVL, how does Symbiotic plan to further differentiate its 'universal staking' offering and capture significant market share over the next 2-3 years?”

  • 2

    “With Symbiotic Points hinting at a future token, what is the strategic thinking around the tokenomics, launch timeline, and how will it benefit early equity holders?”

  • 3

    “Considering the high regulatory barrier in the blockchain and staking space, what are Symbiotic's key strategies for navigating evolving regulations and ensuring long-term compliance?”

Community

Valuation Sentiment

Our model estimates -69% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.